Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

[1] Kovacs JA(1984)Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies Ann Intern Med 100 663-671

[2] Hiemenz JW(2004)Pneumocystis pneumonia N Engl J Med 350 2487-2498

[3] Macher AM(2014)Population-based analysis of invasive fungal infections, France, 2001-2010 Emerg Infect Dis 20 1149-1155

[4] Stover D(2000)Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy Clin Infect Dis 30 S5-14

[5] Murray HW(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators N Engl J Med 338 853-860

[6] Shelhamer J(1992)Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital JAMA 267 832-837

[7] Thomas CF(2002)Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome Clin Infect Dis 34 1098-1107

[8] Limper AH(2002)Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study Clin Infect Dis 35 929-934

[9] Bitar D(2018)Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia Respiration 96 52-65

[10] Lortholary O(2016)Pneumocystis jirovecii pneumonia in the non-HIV-infected population Ann Pharmacother 50 673-679

[1] Kovacs JA(1984)Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies Ann Intern Med 100 663-671

[2] Hiemenz JW(2004)Pneumocystis pneumonia N Engl J Med 350 2487-2498

[3] Macher AM(2014)Population-based analysis of invasive fungal infections, France, 2001-2010 Emerg Infect Dis 20 1149-1155

[4] Stover D(2000)Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy Clin Infect Dis 30 S5-14

[5] Murray HW(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators N Engl J Med 338 853-860

[6] Shelhamer J(1992)Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital JAMA 267 832-837

[7] Thomas CF(2002)Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome Clin Infect Dis 34 1098-1107

[8] Limper AH(2002)Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study Clin Infect Dis 35 929-934

[9] Bitar D(2018)Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia Respiration 96 52-65

[10] Lortholary O(2016)Pneumocystis jirovecii pneumonia in the non-HIV-infected population Ann Pharmacother 50 673-679